Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06484153 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
Track this trial| NCT Number | NCT06484153 |
| Lead Sponsor | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| Conditions | To Evaluate the Efficacy of Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Colorectal Carcinoma, To Evaluate Whether Pirfenidone Can Reshape the Tumor Microenvironment in Colorectal Cancer, Combination of Fruquintinib and Anti-PD-1 Antibody Was Reported to Improve Patient Prognosis in Colorectal Cancer |
| Enrollment | 25 participants |
| Start Date | 2024-07-22 |
| Primary Completion | 2026-07-22 (estimated) |
| Study Completion | 2026-12-30 (estimated) |
| Updated on ClinicalTrials.gov | 2026-08-18 |